This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for lifesciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. . Financial details of the acquisition are not being disclosed.
In addition, MDisrupt will add new features to the marketplace platform through a strategic collaboration with the Association to meet the needs of its members, providing new ways for them to engage with the health technology, health services, medical device, and lifesciences sectors.
Supreme Group is a healthcare commercialization platform company formed following Trinity Hunt’s majority investment in Supreme Optimization , a leading lifescience-focused digital agency. We look forward to supporting the agency as it continues on its growth trajectory.” For more information, visit www.trinityhunt.com.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. One rapidly advancing trend in healthcare and lifesciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world.
The following is a guest article by Steve Lazer, Global Healthcare & LifeSciences CTO at Dell Technologies. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
Earlier in his career, Mr. Kamkolkar served in enterprise data science, digital & AI leadership roles at Sanofi and Novartis. Dr. Rhodes brings more than 25 years of drug discovery, company building and strategic leadership in the biotech industry, including 18 years at Biogen. Jane Rhodes, Ph.D., Jane Rhodes, Ph.D.,
This synergistic partnership is a combination of resources, talent and expertise across two leading science-based organizations with a mission of optimizing and accelerating therapies for patients in need, through greater adoption of digital biomarkers in clinical studies,” said Vik Shah, President and COO of Koneksa.
Keech Combe Shetty, granddaughter of Ivan and Co-CEO of Combe, bolstered the importance of women’s leadership in the health care industry as both a role model and supporter. Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/lifescience, and hospitals.
Over the next five years, healthcare and lifesciences firms will ramp up their digital transformation efforts, driven at least in part by AI and data analytics tools, according to a recent research report.
His board advisory experience includes the Deepbridge Capital LLP Healthcare and LifeSciences investment fund, the Coalition for a Digital Economy committee (Coadec), the Balmain Environmental Conservation Trust (BECT) and the UK Digital Healthcare Council. link] [link]
Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. The facility’s location will further EIT’s current partnerships in the Oxford biotech and technology communities, expand collaborations with the University of Oxford, and support the new Ellison Scholars programme.
Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. As the digital health sector continues to grow, Scotland is well-positioned to play a leading role in shaping the future of healthcare. The company raised $10m in 2022.
New research has found that healthcare organizations around the world have big plans for digital transformation but often stumble when it comes to implementing this process.
The one segment which has stayed relatively even from 2018 has been biotech, 55% that year and 55% again in 2021. Health Populi’s Hot Points: Two underlying pillars for trust are science-based information and transparency. On these factors, the U.S. is indeed in stress-mode. The vaccination-willingness gap in the U.S.
The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the lifesciences. Forbion invests in lifesciences companies that are active in the (bio) pharmaceutical space.
Investment Marks a Significant Milestone in Advancing AI-Based Arrhythmia Care SAN DIEGO–(BUSINESS WIRE)– Vektor Medical , a pioneer in non-invasive, AI-based arrhythmia analysis technology, today announced a $16 million Series A investment co-led by Solas BioVentures and TVM Capital LifeScience. Solas puts patients first.
“BPS has long been recognized worldwide as a trusted and preferred partner of contract manufacturing services for the pharmaceutical and biotech industries. BPS has been a leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharma and biotech industries for decades.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content